Abstract
Purpose of Review
To determine the current evidence for various non-operative therapies in the treatment of carpal tunnel syndrome
Recent Findings
Multiple non-operative treatment modalities exist in the treatment of mild to moderate carpal tunnel syndrome. While certain modalities such as splinting and corticosteroid injections have moderate- to high-quality evidence to support use, other less commonly used treatments have fewer therapeutic indications in the current literature.
Summary
Healthcare providers should be able to initiate the appropriate diagnostic evaluation and assess the utility of non-operative therapies in the treatment of carpal tunnel syndrome. Moreover, healthcare providers should also be able to understand the evidence behind each treatment and the indications for surgical intervention.
Keywords: Carpal tunnel syndrome, Non-operative treatment, Splinting, Injection
Introduction
Carpal tunnel syndrome (CTS) is defined as the compression of the median nerve at the level of the transverse carpal ligament. With an annual prevalence ranging from 1 to 5%, it is the most common compressive neuropathy in the USA with higher prevalence in the female population [1, 2, 3•, 4, 5]. In 2014 alone, the Center for Disease Control (CDC) estimated that over 230,000 patients underwent surgical release of the transverse carpal ligament [6]. However, multiple non-operative treatment modalities for CTS exist with varying rates of success. The healthcare provider treating patients with CTS should be familiar with the risks, benefits, and expected outcomes of non-operative and operative treatment options in order to optimize shared decision-making and patient care.
Presentation and Diagnosis
A thorough history and physical examination are essential to the diagnosis of carpal tunnel syndrome. Patients with CTS typically present with numbness and tingling in the median nerve distribution and less commonly with pain (Fig. 1) [7, 8]. Symptoms are usually worse at nighttime, with 77% of patients who have confirmed CTS on electromyogram (EMG) reporting nighttime numbness or tingling [8–10]. Patients who present late in the course of the disease process may demonstrate profound weakness, thenar atrophy, and/or constant paresthesias (Table 1) [11].
Fig. 1.
Common numbness/tingling distribution in carpal tunnel syndrome
Table 1.
Classification of carpal tunnel syndrome
Classification | Duration of symptoms | Weakness/atrophy | Electrodiagnostic findings |
---|---|---|---|
Mild | Less than 1 year | None present | Abnormal sensory nerve conduction velocity; normal distal motor latency |
Moderate | Less/greater than 1 year | Minimal present | Abnormal sensory nerve conduction velocity; abnormal distal motor latency |
Severe | Greater than 1 year | Marked weakness and/or atrophy | Abnormal (or absent) sensory nerve conduction velocity; abnormal (or absent) distal motor latency |
There is debate as to whether or not the history and physical examination alone are sufficient for the definitive diagnosis of carpal tunnel syndrome [8, 10, 12–14]. Multiple criteria have been developed to predict the likelihood of CTS based solely on the history and physical examination [13, 14]. Despite this, it is the current recommendation of the American Academy of Orthopaedic Surgeons (AAOS) to complete electrodiagnostic testing prior to surgical intervention [15]. The differential diagnosis for carpal tunnel syndrome includes cervical radiculopathy, thoracic outlet syndrome, pronator syndrome, and polyneuropathy [16].
Pathophysiology/Etiology
CTS is caused by increased pressure within the carpal tunnel causing compression of the median nerve. The pathophysiology of CTS is not fully understood. However, it is thought that mechanical factors associated with the compression of the median nerve lead to local ischemia and progressive demyelination of both small and large fibers of the median nerve, resulting in the characteristic symptoms [17–19]. The theory of local ischemia is supported by the oft-rapid resolution of symptoms following surgical release [18].
While the majority of CTS cases are idiopathic, extensive research has been done to explore various etiologies. Potential extrinsic risk factors include trauma, radiocarpal arthritis, and repetitive work-related activities [20–21]. Intrinsic risk factors include diabetes mellitus, hypothyroidism, space-occupying masses, obesity, pregnancy, and mucopolysaccharidoses [8, 22–24].
Non-operative Treatment Modalities
Splinting
Among the non-operative treatment modalities for CTS, splint use has emerged as a first-line option for primary care physicians and upper extremity surgeons alike (Table 2). Splints are typically prescribed for nighttime use but may also be utilized during daytime hours based on patient work and activity demands. By keeping the wrist in a neutral position, splints decrease the extremes of wrist flexion and extension, which have been shown to increase pressure within the carpal tunnel (Fig. 2) [25]. While the majority of splints do not extend past the distal palmar crease, certain splints intentionally extend distally to keep the metacarpophalangeal joints extended. This prevents the lumbrical muscles from retracting proximally, thereby theoretically decreasing the pressure within the carpal tunnel [25]. Evidence supporting the use of splints in mild to moderate CTS is abundant. In a study of 14 women with EMG evidence for bilateral CTS, splint use for 12 weeks yielded significant electrophysiologic improvements in cases of moderate CTS, though improvements were less significant among mild cases [26]. Manente et al. conducted a randomized controlled trial of 83 patients and found that patients treated with a soft hand splint at night for 4 weeks experienced significantly decreased CTS symptoms and functional limitations when compared with a control group [27]. However, no significant differences in electrophysiologic data were encountered between groups.
Table 2.
Non-operative treatment modalities for carpal tunnel syndrome
Treatment Modality | Description | AAOS recommendation |
---|---|---|
Splinting | Wrist-neutral removable wrist splints | Strong—Evidence suggests splinting will improve patient-reported outcomes |
Corticosteroid injection | A single methylprednisolone (varied dosage) performed in the carpal tunnel of the affected side | Strong—Evidence suggests a corticosteroid injection will improve patient-reported outcomes |
Oral medications | Oral non-steroidal anti-inflammatory drugs (NSAIDs), diuretics, gabapentin, pyridoxine | Moderate—Evidence suggests oral medications (NSAIDs, diuretics, etc.) have no benefit on patient-reported outcomes |
Oral corticosteroids (e.g., prednisone) | Moderate—Evidence suggests oral corticosteroid could improve patient-reported outcomes | |
Hand therapy | Targeted exercises focusing on nerve/tendon excursion/gliding | None |
Ultrasound | Pulsed ultrasound therapy at 1–2 MHz over the volar wrist at the level of the carpal tunnel | Limited—Evidence suggests ultrasound therapy has limited benefit on patient-reported outcomes |
Acupuncture | Targeted acupuncture sessions on the affected side at the level of the carpal tunnel 1–2 times per week over 1–2 months | None |
Strength of recommendations courtesy of American Academy of Orthopaedic Surgeons. Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline. 29 Feb. 2016
Fig. 2.
Wrist-neutral splint being worn for the treatment of carpal tunnel syndrome
In order to assess differences between splint types, DeAngelis and colleagues conducted a randomized controlled trial of 120 patients treated with either a soft hand splint or a wrist splint [28]. Both groups experienced significant improvements in wrist pain and function at 3-month follow-up, though these benefits did not persist at a final 9-month follow-up appointment. In a comprehensive review of 19 studies comprising 1190 patients, Page and colleagues concluded that nighttime splinting improves short-term subjective outcomes [29]. As further studies explore optimal wrist position and duration of treatment, splinting will likely remain a mainstay of early outpatient management for patients with mild to moderate CTS.
Steroid Injections
While more invasive than other non-operative modalities, corticosteroid injections (CSI) are commonly used to treat CTS (Table 2). The rationale behind CSI is to decrease pressure within the carpal tunnel by decreasing the inflammation of the tenosynovium passing through it. Studies have shown mixed results in regard to corticosteroid injections (Fig. 3) [30, 31•, 32, 33••, 34]. In a prospective study, Blazar et al. found that 53% of patients were free from symptom recurrence at 6 months. However, only 31% remained symptom-free at 12 months. Despite the higher rate of symptom recurrence, only 44% of patients went on to repeat intervention [32]. Chesterton et al. prospectively randomized patients with mild to moderate CTS to receive one of two possible treatments: (1) a single methylprednisolone carpal tunnel injection, or (2) nighttime splint use. They found that patients who received a single injection had significantly better scores on the Boston Carpal Tunnel Questionnaire (BCTQ), a disease-specific measure of self-reported symptom severity and functional status [33••].
Fig. 3.
A corticosteroid injection being performed for the treatment of carpal tunnel syndrome
Atroshi et al. performed a prospective, randomized study comparing two different doses of methylprednisolone injections with placebo. Patients demonstrated improved symptoms at the 10-week post injection follow-up appointment with both doses of methylprednisolone versus placebo. At 1-year follow-up; however, there was no significant difference in reported symptoms [35]. Patients who received the higher dose methylprednisolone injection were less likely to have undergone surgical intervention at 1 year. Complication rates from corticosteroid injections in the carpal tunnel are rare, with local injection site pain being the most common in roughly 13% of patients [36].
Oral Medications
Multiple different classes of medication have been used in the treatment of CTS. These include non-steroidal anti-inflammatory drugs (NSAIDs), diuretics, and steroids. Both NSAIDs and diuretics have demonstrated no clear benefit and as such are not recommended in the treatment algorithm [37].
Currently, the AAOS has a moderate strength recommendation for the use of oral steroids in the treatment of CTS. The use of oral steroids has shown some benefit in the short-term treatment of CTS. Long-term effectiveness is debatable [38–40].
Hand Therapy
Hand therapy aims to facilitate the gliding of tendons and nerves within the carpal tunnel in order to maximize nerve and tendon excursion and to improve axonal transport and nerve conduction [41, 42]. In a randomized trial comparing splint use alone with splint use with nerve and tendon gliding exercises, Akalin et al. found that both groups experienced significant improvements at 4 weeks, though the tendon and nerve mobilization group experienced slightly greater improvements with a significant benefit in lateral pinch strength [43]. Baker and colleagues conducted a trial of splinting and therapy exercises and found that a standard wrist splint with lumbrical-intensive stretching exercises yielded improved subjective function persisting up to 24 weeks after initial intervention [44].
Along with gliding exercises, newer research has focused on improving tendon and nerve mobility via iontophoresis, the transdermal propulsion of ionized medication through a patch applied to the volar surface of the wrist. Data is limited thus far, with one trial by Gokoglu and colleagues showing symptomatic improvement at 2- and 8-week follow-ups following iontophoresis of dexamethasone sodium phosphate [45]. These improvements, however, were inferior to a matched cohort of patients receiving corticosteroid injection. Future studies are needed to further elucidate whether tendon and nerve gliding exercises, with or without iontophoretic augmentation, can translate into measurable electrophysiologic improvements in the management of CTS.
Ultrasound
Though conventionally used for diagnostic purposes and as an adjunct for targeted injections, ultrasound has also been utilized as a standalone therapeutic modality for mild to moderate CTS (Fig. 4). Ultrasound imparts high-frequency waves, which have both thermal and non-thermal effects, decreasing inflammation and stimulating nerve regeneration via enhanced blood flow and membrane permeability [46, 47]. To date, randomized trials have shown mixed results in regard to the clinical utility of ultrasound therapy in CTS. Ebenbichler and colleagues conducted a randomized controlled trial of 34 patients with EMG-confirmed bilateral CTS treated with active ultrasound therapy in one wrist and a sham procedure in the contralateral wrist [48]. Pulsed ultrasound at 1 MHz, 1.0 W/cm [2] applied to the carpal tunnel region over 15 min for ten consecutive days, followed by twice weekly treatments for five additional weeks, yielded improved pain and paresthesia symptoms, reduced sensory loss, improved median nerve motor distal latency and nerve conduction velocity, and increased grip and pinch strength when compared with sham ultrasound. Treatment effects persisted up to 6 months. Other studies investigating ultrasound as an adjunct to other treatment, such as splinting or anti-inflammatory medications, have shown additional promise [49, 50].
Fig. 4.
Patient undergoing ultrasound therapy for carpal tunnel syndrome
However, no additional placebo-controlled studies have emerged to support the independent use of ultrasound, with certain studies calling its utility into question [51–53]. A Cochrane review by Page and colleagues concluded that there is only poor evidence based on limited data to suggest that therapeutic ultrasound is more effective than placebo for treatment of CTS [54]. Additional randomized, placebo-controlled trials are needed to further investigate the potential short-term and long-term benefits of ultrasound as a standalone or adjunct treatment modality.
Acupuncture
With origins in Eastern medicine, acupuncture therapy has been utilized worldwide in the management of mild to moderate CTS. Acupuncture aims to stimulate trigger points along the meridian, a proposed pathway of energy (qi) through the body. Optimizing this energy pathway is thought to provide symptomatic relief of CTS without altering mechanical pressures within the carpal tunnel (Fig. 5). Though the precise mechanism of action remains unknown, proposed theories include promoting a neuromodulatory effect on pain perception by triggering endogenous central nervous system analgesic production and activating anti-inflammatory pathways [55–56]. Studies exploring the use of acupuncture in CTS have yielded mixed results. Yang and colleagues compared acupuncture needling (eight sessions over 4 weeks) with 4 weeks of oral prednisolone (20 mg daily for 2 weeks, followed by 10 mg for 2 weeks) [57]. The authors found that both interventions improved symptoms, though the acupuncture group experienced less nocturnal awakening and decreased distal motor latencies after 4 weeks compared with the steroid group. In contrast, a randomized controlled trial of acupuncture therapy versus placebo acupuncture for 6 weeks by Yao and colleagues found that both groups demonstrated improvements from baseline and that acupuncture was not superior to placebo [58].
Fig. 5.
Anatomic locations of two acupoints in treatment of carpal tunnel syndrome
In a recent Cochrane review compiling 12 studies and 869 patients, Choi et al. concluded that acupuncture may have little or no short-term effect on CTS symptoms in comparison with placebo or sham procedures [59]. This was largely attributed to heterogeneity of the studies and the risk of bias. The authors also stated that the adverse effects of acupuncture, such as skin bruising and local pain after needle insertion, are inconsistently reported among trials and must be documented to comprehensively assess risks and benefits prior to recommending treatment. Moving forward, future studies with improved methodology in regard to enrollment criteria, indications, and outcomes will be needed to assess the role of acupuncture as an independent therapeutic modality.
Operative Intervention
While non-operative treatment strategies are often employed prior to surgical intervention, it is important for both primary care providers and treating hand surgeons to recognize when operative treatment is appropriate. Many patients with electrodiagnostic findings of moderate to severe carpal tunnel syndrome (Table 1) are best treated with earlier surgical release. In fact, recovery after surgery is often better for those with mild to moderate disease than those with severe disease [60]. In the case of a patient who presents with mild CTS, the aforementioned non-operative modalities may prove beneficial. The duration of non-operative treatment may also vary based on surgeon experience or patient preference, with a high variability in treatment duration currently reported in the literature [61, 62]. Regardless of treatment modality, it is important that a shared decision-making model is utilized in discussing the diagnosis and multiple treatment options available for CTS in order to optimize care of the patient.
Conclusions
Carpal tunnel syndrome is the most common compressive neuropathy, afflicting thousands of patients annually. Fortunately, numerous non-operative treatment options exist to help treat patients with mild to moderate disease. The treating healthcare provider should have an understanding of these treatment modalities and utilize them accordingly.
Compliance with Ethical Standards
Conflict of Interest
Dr. Ostergaard and Dr. Meyer declare that they have no conflict of interest. Dr. Earp has stock ownership in Johnson & Johnson and Pfizer.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Footnotes
This article is part of the Topical Collection on Compressive Neuropathies in the Upper Extremity
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Peter J. Ostergaard, Email: postergaard@partners.org
Maximilian A. Meyer, Email: mmeyer2@mgh.harvard.edu
Brandon E. Earp, Email: bearp@bwh.harvard.edu
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosen I. Prevalence of carpal tunnel syndrome in a general population. JAMA. 1999;282(2):153–158. doi: 10.1001/jama.282.2.153. [DOI] [PubMed] [Google Scholar]
- 2.Bickel KD. Carpal tunnel syndrome. J Hand Surg Am. 2010;35:147–152. doi: 10.1016/j.jhsa.2009.11.003. [DOI] [PubMed] [Google Scholar]
- 3.• Hermiz SJ, Kalliainen LK. Evidence-based medicine: current evidence in the diagnosis and management of carpal tunnel syndrome. Plast Reconstr Surg. 2017;140(1):120–9. This review article provides a concise overview of evidence-based treatment modalities, both operative and non-operative, in the management of carpal tunnel syndrome. Beyond diagnosis and treatment, the authors discuss management of carpal tunnel syndrome in the context of healthcare costs for both patients and providers alike. [DOI] [PubMed]
- 4.Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum. 2007;58(1):26–35. doi: 10.1002/art.23176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tanaka S, Wild DK, Seligman PJ, Behrens V, Cameron L, Putz-Anderson V. The US prevalence of self-reported carpal tunnel syndrome: 1988 National Health Interview Survey Data. Am J Public Health. 1994;84(11):1846–1848. doi: 10.2105/AJPH.84.11.1846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Centers for Disease Control and Prevention. CDC - NIOSH Update - New NIOSH report evaluating musculoskeletal disorders and traumatic injuries in a poultry processing plant. www.cdc.gov/niosh/updates/upd-03-27-14_b.html.
- 7.D’arcy CA, McGee S. Does this patient have carpal tunnel syndrome? JAMA. 2000;283(23):3110–3117. doi: 10.1001/jama.283.23.3110. [DOI] [PubMed] [Google Scholar]
- 8.Mccabe SJ. Diagnosis of carpal tunnel syndrome. J Hand Surg Am. 2010;35(4):646–648. doi: 10.1016/j.jhsa.2009.12.034. [DOI] [PubMed] [Google Scholar]
- 9.Katz JN, Larson MG, Sabra A, Krarup C, Atirrat CR, Sethi R, Eaton HM, Fossel AH, Liang MH. The carpal tunnel syndrome: diagnostic utility of the history and physical examination findings. Ann Intern Med. 1990;112(5):321–327. doi: 10.7326/0003-4819-112-5-321. [DOI] [PubMed] [Google Scholar]
- 10.Wainner RS, Fritz JM, Irrgang JJ, Delitto A, Allison S, Boninger ML. Development of a clinical prediction rule for the diagnosis of carpal tunnel syndrome. Arch Phys Med Rehabil. 2005;86(4):609–618. doi: 10.1016/j.apmr.2004.11.008. [DOI] [PubMed] [Google Scholar]
- 11.Middleton SD, Anakwe RE. Carpal tunnel syndrome. BMJ. 2014;349:6437. doi: 10.1136/bmj.g6437. [DOI] [PubMed] [Google Scholar]
- 12.Graham B. The value added by electrodiagnostic testing in the diagnosis of carpal tunnel syndrome. J Bone Joint Surg Am. 2008;90(12):2587–2593. doi: 10.2106/JBJS.G.01362. [DOI] [PubMed] [Google Scholar]
- 13.Graham B, Regehr G, Naglie G, Wright JG. Development and validation of diagnostic criteria for carpal tunnel syndrome. J Hand Surg Am. 2006;31(6):919–924. [PubMed] [Google Scholar]
- 14.Lane LB, Starecky M, Olson A, Kohn N. Carpal tunnel syndrome diagnosis and treatment: a survey of members of the American Society for Surgery of the Hand. J Hand Surg Am. 2014;39(11):2181–2187. doi: 10.1016/j.jhsa.2014.07.019. [DOI] [PubMed] [Google Scholar]
- 15.American Academy of Orthopaedic Surgeons. Management of carpal tunnel syndrome evidence-based clinical practice guideline. www.aaos.org/ctsguideline. 2016. [DOI] [PubMed]
- 16.Amadio PC. Differential diagnosis of carpal tunnel syndrome. In: Luchetti R, Amadio P, editors. Carpal tunnel syndrome. Berlin: Springer; 2007. pp. 89–94. [Google Scholar]
- 17.Chammas M. Carpal tunnel syndrome. Chir Main. 2014;33(2):75–94. doi: 10.1016/j.main.2013.11.010. [DOI] [PubMed] [Google Scholar]
- 18.Gelberman RH, Rydevik BL, Pess GM, Szabo RM, Lundborg G. Carpal tunnel syndrome. A scientific basis for clinical care. Orthop Clin North Am. 1988;19(1):115–124. [PubMed] [Google Scholar]
- 19.Werner RA, Michael A. Carpal tunnel syndrome: pathophysiology and clinical neurophysiology. Clin Neurophysiol. 2002;113(9):1373–1381. doi: 10.1016/S1388-2457(02)00169-4. [DOI] [PubMed] [Google Scholar]
- 20.Lozano-Calderón S, Anthony S, Ring D. The quality and strength of evidence for etiology: example of carpal tunnel syndrome. J Hand Surg Am. 2008;33(4):525–538. doi: 10.1016/j.jhsa.2008.01.004. [DOI] [PubMed] [Google Scholar]
- 21.Nathan PA, Istvan JA, Meadows KD. A longitudinal study of predictors of research-defined carpal tunnel syndrome in industrial workers: findings at 17 years. J Hand Surg Br. 2005;30(6):593–598. doi: 10.1016/J.JHSB.2005.06.019. [DOI] [PubMed] [Google Scholar]
- 22.Bäumer T, Buhring N, Schelle T, Munchau A, Muschol N. Nerve ultrasound in clinical management of carpal tunnel syndrome in mucopolysaccharidosis. Dev Med Child Neurol. 2016;58(11):1172–1179. doi: 10.1111/dmcn.13127. [DOI] [PubMed] [Google Scholar]
- 23.De Krom MC, Kester AD, Knipschild PG, Spaans F. Risk factors for carpal tunnel syndrome. Am J Epidemiology. 1990;132(6):1102–1110. doi: 10.1093/oxfordjournals.aje.a115753. [DOI] [PubMed] [Google Scholar]
- 24.Kwon JY, Ko K, Sohn YB, Kim SJ, Park SW, Kim SH, Cho SY, Jin DK. High prevalence of carpal tunnel syndrome in children with mucopolysaccharidosis type II (Hunter syndrome) Am J Med Genet A. 2011;155(6):1329–1335. doi: 10.1002/ajmg.a.34013. [DOI] [PubMed] [Google Scholar]
- 25.Weiss ND, Gordon L, Bloom T, So Y, Rempel DM. Position of the wrist associated with the lowest carpal-tunnel pressure. J Bone Joint Surg Am. 1995;77(11):1695–1699. doi: 10.2106/00004623-199511000-00008. [DOI] [PubMed] [Google Scholar]
- 26.Karsidag SSS, Hackikerim Karsidag S, Ayalp S. Long term and frequent electrophysiological observation in carpal tunnel syndrome. Eura Medicophys. 2007;43(3):327–332. [PubMed] [Google Scholar]
- 27.Manente GTF, Di Blasio F, Staniscia T, Romano F, Uncini A. An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle Nerve. 2001;24(8):1020–1025. doi: 10.1002/mus.1105. [DOI] [PubMed] [Google Scholar]
- 28.DeAngelis MVPF, Di Giovanni P, Staniscia T, Uncini A. Efficacy of a soft hand brace and a wrist splint for carpal tunnel syndrome: a randomized controlled study. Acta Neurol Scand. 2009;119(1):68–74. doi: 10.1111/j.1600-0404.2008.01072.x. [DOI] [PubMed] [Google Scholar]
- 29.Page MJ, O’Connor D, Pitt V. Splinting for carpal tunnel syndrome. Cochrane Database of Syst Rev. 2012;11(7). [DOI] [PMC free article] [PubMed]
- 30.Armstrong T, Devor W, Borschel L. Contreras. Intracarpal steroid injection is safe and effective for short-term management of carpal tunnel syndrome. Muscle Nerve. 2004;29(1):82–88. doi: 10.1002/mus.10512. [DOI] [PubMed] [Google Scholar]
- 31.Blazar PE, Floyd WE, Han CH, Rozental TD, Earp BE. Prognostic indicators for recurrent symptoms after a single corticosteroid injection for carpal tunnel syndrome. J Bone Joint Surg Am. 2015;97(19):1563–1570. doi: 10.2106/JBJS.N.01162. [DOI] [PubMed] [Google Scholar]
- 32.Boyer MI. Corticosteroid injection for carpal tunnel syndrome. J Hand Surg Am. 2008;33(8):1414–1416. doi: 10.1016/j.jhsa.2008.06.023. [DOI] [PubMed] [Google Scholar]
- 33.Chesterton LS, Blagojevis-Bucknall M, BurtonC DKS, Davenport G, Jowett SM, Myers HL, Oppong R, Rathoud-Mistry T, van der Windt DA, Hay EM, Roddy E. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS Trial): an open-label, parallel group, randomised controlled trial. Lancet. 2018;392(10156):1423–1433. doi: 10.1016/S0140-6736(18)31572-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Dammers JW, Veering MM, Vermeulen M. Methylprednisolone injection improved symptoms for 1 year in patients with the carpal tunnel syndrome. BMJ. 1999;319(7214):884–886. doi: 10.1136/bmj.319.7214.884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Atroshi I, Ranstam J. Methylprednisolone injections for the carpal tunnel syndrome. Ann Intern Med. 2013;159(12):858–859. doi: 10.7326/0003-4819-159-12-201312170-00020. [DOI] [PubMed] [Google Scholar]
- 36.Kaile E, Bland JDP. Safety of corticosteroid injection for carpal tunnel syndrome. J Hand Surg Euro Vol. 2017;43(3):296–302. doi: 10.1177/1753193417734426. [DOI] [PubMed] [Google Scholar]
- 37.Chang MH, Chiang HT, Lee SS, Ger LP, Lo YK. Oral drug of choice in carpal tunnel syndrome. Neurology. 1998;51(2):390–393. doi: 10.1212/WNL.51.2.390. [DOI] [PubMed] [Google Scholar]
- 38.Alam MM, Bari MS, Ullah AK, Haque A. Short term low dose oral steroid- an effective treatment of carpal tunnel syndrome. Dinajpur Med Col J. 2008;1(1):33–39. [Google Scholar]
- 39.Chang MH, Ger LP, Hsieh PF, Huang SY. A randomised clinical trial of oral steroids in the treatment of carpal tunnel syndrome: a long term follow up. J Neurol Neurosurg Psychiatry. 2002;73(6):710–714. doi: 10.1136/jnnp.73.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Huisstede BM, Randsdorp MS, van den Brink J, Franke TPC, Koes BW, Hoogvliet P. Effectiveness of oral pain medication and corticosteroid injections for carpal tunnel syndrome: a systematic review. Arch Phys Med Rehabil. 2018;99(8):1609–1622. doi: 10.1016/j.apmr.2018.03.003. [DOI] [PubMed] [Google Scholar]
- 41.Kim SD. Efficacy of tendon and nerve gliding exercises for carpal tunnel syndrome: a systematic review of randomized controlled trials. J Phys Ther Sci. 2015;27(8):2645–2648. doi: 10.1589/jpts.27.2645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Muller M, Tsui D, Schnurr R, Biddulph-Deisroth L, Hard J, MacDermid JC. Effectiveness of hand therapy interventions in primary management of carpal tunnel syndrome: a systematic review. J Hand Ther. 2004;17(2):210–228. doi: 10.1197/j.jht.2004.02.009. [DOI] [PubMed] [Google Scholar]
- 43.Akalin EEO, Peker O, Senocak O, Tamci S, Gulbahar S, Cakmur R, Oncel S. Treatment of carpal tunnel syndrome with nerve and tendon gliding exercises. Am J Phys Med Rehabil. 2002;81(2):108–113. doi: 10.1097/00002060-200202000-00006. [DOI] [PubMed] [Google Scholar]
- 44.Baker NA, Livengood HM. Symptom severity and conservative treatment for carpal tunnel syndrome in association with eventual carpal tunnel release. J Hand Surg Am. 2014;39(9):1792–1798. doi: 10.1016/j.jhsa.2014.04.034. [DOI] [PubMed] [Google Scholar]
- 45.Gokoglu FG, Yorgancoglu ZR, Okumus M, Ceceli E, Kocaoglu S. Evaluation of iontophoresis and local corticosteroid injection in the treatment of carpal tunnel syndrome. Am J Phys Med Rehabil. 2005;84(2):92–96. doi: 10.1097/01.PHM.0000151942.49031.DD. [DOI] [PubMed] [Google Scholar]
- 46.Hong CZLH, Yu J. Ultrasound thermotherapy effect on the recovery of nerve conduction in experimental compression neuropathy. Arch Phys Med Rehabil. 1988;69(6):410–414. [PubMed] [Google Scholar]
- 47.Kramer J. Ultrasound: evaluation of its mechanical and thermal effects. Arch Phys Med Rehab. 1984;65(5):223–227. [PubMed] [Google Scholar]
- 48.Ebenbichler GRRK, Nicolakis P, Wiesinger GF, Uhl F, Ghanem AH, Fialka V. Ultrasound treatment for treating the carpal tunnel syndrome: randomised “sham” controlled trial. Br Med J. 1998;7(7133):731–735. doi: 10.1136/bmj.316.7133.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Armagan OBF, Ozgen M, Mehmetoglu O, Oner S. Effects of placebo-controlled continuous and pulsed ultrasound treatments on carpal tunnel syndrome: a randomized trial. Clinics (Sao Paulo) 2014;69(8):524–528. doi: 10.6061/clinics/2014(08)04. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Piravej KBJ. Effect of ultrasound thermotherapy in mild to moderate carpal tunnel syndrome. J Med Assoc Thail. 2004;87(2):100–106. [PubMed] [Google Scholar]
- 51.Oztas OTB, Bora I, Karakaya MK. Ultrasound therapy effect in carpal tunnel syndrome. Arch Phys Med Rehab. 1998;79(12):1540–1544. doi: 10.1016/S0003-9993(98)90416-6. [DOI] [PubMed] [Google Scholar]
- 52.Schuhfried OVD, Kollman C, Pieber K, Paternostro-Sluga T. Effects of pulsed ultrasound therapy on sensory nerve conduction parameters and the pain threshold perceptions in humans. PM&R. 2017;9(8):781–786. doi: 10.1016/j.pmrj.2016.11.009. [DOI] [PubMed] [Google Scholar]
- 53.Yildiz NAN, Gungen GO, Sanal E, Akkaya N, Topuz O. Comparison of ultrasound and ketoprofen phonophoresis in the treatment of carpal tunnel syndrome. J Back Musculoskelet Rehabil. 2011;24(1):39–47. doi: 10.3233/BMR-2011-0273. [DOI] [PubMed] [Google Scholar]
- 54.Page MJOCD, Pitt V, Massy-Westropp N. Therapeutic ultrasound for carpal tunnel syndrome. Cochrane Database Syst Rev. 2013;3. [DOI] [PMC free article] [PubMed]
- 55.Foster JMSB. The mechanisms of acupuncture analgesia. Br J Hosp Med. 1987;38(4):308–312. [PubMed] [Google Scholar]
- 56.Kavoussi BRB. The neuroimmune basis of anti-inflammatory acupuncture. Intregr Cancer Ther. 2007;6(3):251–257. doi: 10.1177/1534735407305892. [DOI] [PubMed] [Google Scholar]
- 57.Yang CPHC, Wang NH, Li TC, Hwang KL, Yu SC, Chang MH. Acupuncture in patients with carpal tunnel syndrome: a randomized controlled trial. Clin J Pain. 2009;25(4):327–333. doi: 10.1097/AJP.0b013e318190511c. [DOI] [PubMed] [Google Scholar]
- 58.Yao EGP, Henricson E, Abresch T, Kim J, Han J, Wang K, Zhao H. Randomized controlled trial comparing acupuncture with placebo acupuncture for the treatment of carpal tunnel syndrome. PM&R. 2012;4(5):367–373. doi: 10.1016/j.pmrj.2012.01.008. [DOI] [PubMed] [Google Scholar]
- 59.Choi GH, Wieland LS, Lee H, Sim H, Lee MS, Shin BC. Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome. Cochrane Database Syst Rev. 2018;12:cd011215. doi: 10.1002/14651858.CD011215.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Kronlage SC, Menendez ME. The benefit of carpal tunnel release in patients with electrophysiologically moderate and severe disease. J Hand Surg Am. 2015;40(3):438–444. doi: 10.1016/j.jhsa.2014.12.012. [DOI] [PubMed] [Google Scholar]
- 61.Baker NA, Moehling KK, Rubinstein EN, Wollstein R, Gustafson NP, Baratz M. The comparative effectiveness of combined lumbrical muscle splints and stretches on symptoms and function in carpal tunnel syndrome. Arch Phys Med Rehabil. 2012;93(1):1–10. doi: 10.1016/j.apmr.2011.08.013. [DOI] [PubMed] [Google Scholar]
- 62.Hall B, Lee HC, Fitzgerald H, Byrne B, Barton A, Lee AH. Investigating the effectiveness of full-time wrist splinting and education in the treatment of carpal tunnel syndrome: a randomized controlled trial. Am J Occup Ther. 2013;67(4):448–459. doi: 10.5014/ajot.2013.006031. [DOI] [PubMed] [Google Scholar]